About Neurosterix
Harnessing the power of allosteric modulators to design targeted, next-generation therapies for complex neuropsychiatric disorders.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B
Global Headquarters
Undisclosed
Tracked Since
Nov 13, 2026
Web & Domain Identity
Official Website
neurosterix.com
Domain Registered Date
Undisclosed
Social & Network Presence
X / Twitter Profile
@neurosterix
LinkedIn Corporate
Company Profile
Company Milestones & Timeline
- Capital Raise
Raised $105,000,000 · Series-B
Backed by RTW Investments
- Capital Raise
Raised $63,000,000 · Series-A
Backed by Perceptive Advisors
Investors & Backers
Perceptive Advisors
Lead
RTW Investments
Lead
Acorn Bioventures
Addex Therapeutics
Xontogeny
Funding History
Series-B equity
· Nov 13, 2026
Round backers: RTW Investments
$105,000,000 citybiz.co
Series-A equity
· Apr 3, 2024
Round backers: Perceptive Advisors
$63,000,000 xontogeny.com
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allTesorai
tesorai.com
Seed Nov 2026
Commit Biologics
commitbio.com
Seed Aarhus · Nov 2026
Human Biome
human-biome.com
Series-A Warsaw · Nov 2026
MedInTech
medintech.co.kr
Series-B Seoul · Nov 2026
INFevo
infevo.ai
Seed Beijing · Nov 2026
Seawolf Therapeutics
seawolftx.com
Seed San Diego · Nov 2026